-
Reliability of intestinal ultrasound for evaluating Crohn's disease activity using point-of-care and central reading. Clin Gastroenterol Hepatol. 2024 Aug 27.
Goodsall TM, An YK, Andrews JM, Begun J, Friedman AB, Lee A, Lewindon PJ, Spizzo P, Rodgers N, Taylor KM, White LS, Wilkens R, Wright EK, Zou L, Maguire BR, Parker CE, Rémillard J, Novak KL, Panaccione R, Feagan BG, Jairath V, Ma C, Bryant RV. PMID: 39209200.
View in:
PubMed Mentions:
-
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. Radiology. 2024 Aug; 312(2):e233039.
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG, Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium. PMID: 39105637.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Aliment Pharmacol Ther. 2024 04; 59(8):928-940.
Lu C, Rosentreter R, Delisle M, White M, Parker CE, Premji Z, Wilson SR, Baker ME, Bhatnagar G, Begun J, Bruining DH, Bryant R, Christensen B, Feagan BG, Fletcher JG, Jairath V, Knudsen J, Kucharzik T, Maaser C, Maconi G, Novak K, Rimola J, Taylor SA, Wilkens R, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) consortium. PMID: 38436124.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Use of external control arms in immune-mediated inflammatory diseases: a systematic review. BMJ Open. 2023 12 09; 13(12):e076677.
Zayadi A, Edge R, Parker CE, Macdonald JK, Neustifter B, Chang J, Zhong G, Singh S, Feagan BG, Ma C, Jairath V. PMID: 38070932; PMCID: PMC10729249.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity. Clin Gastroenterol Hepatol. 2023 Dec 04.
Solitano V, Schaeffer DF, Hogan M, Vande Casteele N, Pai RK, Zou G, Pai RK, Parker CE, Rémillard J, Christensen B, Danese S, Peyrin-Biroulet L, Panaccione R, Sands BE, D'Haens G, Feagan BG, Ma C, Jairath V. PMID: 38056798.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. J Crohns Colitis. 2023 Nov 24; 17(11):1800-1816.
Solitano V, Vuyyuru SK, MacDonald JK, Zayadi A, Parker CE, Narula N, Peyrin-Biroulet L, Danese S, Feagan BG, Singh S, Ma C, Jairath V. PMID: 37317532.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series. Pulm Circ. 2023 Jul; 13(3):e12289.
Colglazier E, Ng AJ, Parker C, Woolsey D, Holmes R, Dsouza A, Becerra J, Stevens L, Nawaytou H, Keller RL, Fineman JR. PMID: 37731624; PMCID: PMC10507570.
View in:
PubMed Mentions:
1
-
Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis. Dig Dis Sci. 2023 09; 68(9):3702-3713.
Vuyyuru SK, Solitano V, Hogan M, MacDonald JK, Zayadi A, Parker CE, Sands BE, Panaccione R, Narula N, Feagan BG, Singh S, Jairath V, Ma C. PMID: 37378711; PMCID: PMC10981469.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
View in:
PubMed Mentions:
-
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology. 2022 10; 163(4):950-964.
CORE-IBD Collaborators, Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Atreya R, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen B, Colombel JF, Danese S, Dignass A, Dubinsky MC, Fleshner PR, Gearry RB, Hanauer SB, Hart A, Kotze PG, Kucharzik T, Lakatos PL, Leong RW, Magro F, Panés J, Peyrin-Biroulet L, Ran Z, Regueiro M, Singh S, Spinelli A, Steinhart AH, Travis SP, van der Woude CJ, Yacyshyn B, Yamamoto T, Allez M, Bemelman WA, Lightner AL, Louis E, Rubin DT, Scherl EJ, Siegel CA, Silverberg MS, Vermeire S, Parker CE, McFarlane SC, Guizzetti L, Smith MI, Vande Casteele N, Feagan BG, Jairath V. PMID: 35788348.
View in:
PubMed Mentions:
14 Fields:
Translation:
Humans
-
Caveolin-1 associated with severe (pediatric-onset) presentation of pulmonary arterial hypertension. Pulm Circ. 2022 Jul; 12(3):e12100.
Farrell R, Colglazier E, Parker C, Stevens L, Austin ED, Fineman JR. PMID: 35864912; PMCID: PMC9294289.
View in:
PubMed Mentions:
2
-
View in:
PubMed Mentions:
3
-
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials. J Crohns Colitis. 2022 Jun 24; 16(5):717-736.
Almradi A, Sedano R, Hogan M, Zou GY, MacDonald JK, Parker CE, Hanzel J, Crowley E, Singh S, D'Haens G, Sandborn WJ, Feagan BG, Ma C, Jairath V. PMID: 34758084.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
View in:
PubMed Mentions:
4
-
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. BioDrugs. 2021 Nov; 35(6):715-733.
Bots SJ, Parker CE, Brandse JF, Löwenberg M, Feagan BG, Sandborn WJ, Jairath V, D'Haens G, Vande Casteele N. PMID: 34797516; PMCID: PMC9826743.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales? Am J Respir Crit Care Med. 2020 12 01; 202(11):1587-1589.
Amin EK, Austin ED, Parker C, Colglazier E, Nawaytou H, Leary PJ, Hemnes AR, Teitel D, Fineman JR. PMID: 32692583.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans